Chronic high-level multidrug-resistant Campylobacter coli enterocolitis in an agammaglobulinemia patient: gentamicin efficacy.
CONCLUSION: Oral aminoglycoside might be the most appropriate choice for eradication of persistent Campylobacter in the intestinal tract for macrolide- and fluoroquinolone-resistant isolate in agammaglobulinemia patients with chronic diarrhea or relapsing systemic infections.
PMID: 32353415 [PubMed - as supplied by publisher]
Source: Medecine et Maladies Infectieuses - Category: Infectious Diseases Tags: Med Mal Infect Source Type: research
More News: Azithromycin | Campylobacter | Cipro | Ciprofloxacin | Erythromycin | Gastroenteritis | Infectious Diseases | Multidrug Resistance | Tetracycline | X-Linked Agammaglobulinemia (XLA) | Zithromax